Cargando…

Establishing the suitability of model‐integrated evidence to demonstrate bioequivalence for long‐acting injectable and implantable drug products: Summary of workshop

On November 30, 2021, the US Food and Drug administration (FDA) and the Center for Research on Complex Generics (CRCG) hosted a virtual public workshop titled “Establishing the Suitability of Model‐Integrated Evidence (MIE) to Demonstrate Bioequivalence for Long‐Acting Injectable and Implantable (LA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Yuqing, Zhang, Peijue, Yoon, Miyoung, Zhu, Hao, Kohojkar, Ameya, Hooker, Andrew C., Ducharme, Murray P., Gobburu, Jogarao, Cellière, Géraldine, Gajjar, Parmesh, Li, Bing V., Velagapudi, Raja, Tsang, Yu Chung, Schwendeman, Anna, Polli, James, Fang, Lanyan, Lionberger, Robert, Zhao, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196434/ https://www.ncbi.nlm.nih.gov/pubmed/36710372 http://dx.doi.org/10.1002/psp4.12931

Ejemplares similares

Regulatory utility of mechanistic modeling to support alternative bioequivalence approaches: A workshop overview
por: Babiskin, Andrew, et al.
Publicado: (2023)

Quantitative methods and modeling to assess COVID‐19‐interrupted in vivo pharmacokinetic bioequivalence studies with two reference batches
por: Gong, Yuqing, et al.
Publicado: (2022)

Regulatory utility of physiologically‐based pharmacokinetic modeling to support alternative bioequivalence approaches and risk assessment: A workshop summary report
por: Wu, Fang, et al.
Publicado: (2023)

Increasing impact of quantitative methods and modeling in establishment of bioequivalence and characterization of drug delivery
por: Yoon, Miyoung, et al.
Publicado: (2023)

Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary report
por: Al Shoyaib, Abdullah, et al.
Publicado: (2023)

Bayesian model-guided antimicrobial therapy in pediatrics
por: Bunn, Haden T., et al.
Publicado: (2023)

Integrating In Vitro, Modeling, and In Vivo Approaches to Investigate Warfarin Bioequivalence
por: Zhang, X, et al.
Publicado: (2017)

Dosage Regimens for Meropenem in Children with Pseudomonas Infections Do Not Meet Serum Concentration Targets
por: Hassan, Hazem E., et al.
Publicado: (2019)

An Innovative Disease‐Drug‐Trial Framework to Guide Binge Eating Disorder Drug Development: A Case Study for Topiramate
por: Kalaria, Shamir N., et al.
Publicado: (2019)

Population Pharmacokinetics of Vancomycin in Pregnant Women
por: Goyal, Rahul K., et al.
Publicado: (2022)

Research and Education Needs for Complex Generics
por: Stern, Sydney, et al.
Publicado: (2021)

Population Pharmacokinetic Modelling of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Patients with Haemophilia B
por: Diao, Lei, et al.
Publicado: (2014)

Evaluation of model‐based bioequivalence approach for single sample pharmacokinetic studies
por: Tardivon, Coralie, et al.
Publicado: (2023)

Mechanistic Oral Absorption Modeling and Simulation for Formulation Development and Bioequivalence Evaluation: Report of an FDA Public Workshop
por: Zhang, X, et al.
Publicado: (2017)

Benefit‐risk assessment of nivolumab 240 mg flat dose relative to 3 mg/kg Q2W regimen in Japanese patients with advanced cancers
por: Bei, Di, et al.
Publicado: (2020)

Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose
por: Huang, Jie, et al.
Publicado: (2020)

Simulations demonstrate a simple network to be sufficient to control branch point selection, smooth muscle and vasculature formation during lung branching morphogenesis
por: Cellière, Géraldine, et al.
Publicado: (2012)

Evaluation of the Bioequivalence of Acarbose in Healthy Chinese People
por: Chen, Yan, et al.
Publicado: (2021)

Single-Dose Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate Formulation, in Healthy Adults and in Adolescents and Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann, et al.
Publicado: (2018)

A Practice‐Based, Clinical Pharmacokinetic Study to Inform Levetiracetam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration (PADRE‐01)
por: Kalaria, Shamir N., et al.
Publicado: (2020)

Effect of the Similarity of Formulations and Excipients of Approved Generic Drug Products on In Vivo Bioequivalence for Putative Biopharmaceutics Classification System Class III Drugs
por: Ren, Ping, et al.
Publicado: (2023)

plasticity of TGF-β signaling
por: Cellière, Geraldine, et al.
Publicado: (2011)

Bioequivalence: tried and tested
por: Schall, Robert, et al.
Publicado: (2010)

Bioequivalence studies in Morocco
por: Zaoui, Sanaa, et al.
Publicado: (2020)

Bioequivalence data analysis
por: Park, Gowooni, et al.
Publicado: (2020)

Evaluation of pharmacokinetics and safety with bioequivalence of Amlodipine in healthy Chinese volunteers: Bioequivalence Study Findings
por: Wang, Tongtong, et al.
Publicado: (2020)

Development of a Pediatric Relative Bioavailability/Bioequivalence Database and Identification of Putative Risk Factors Associated With Evaluation of Pediatric Oral Products
por: Pawar, Gopal, et al.
Publicado: (2021)

Clinical Pharmacology‐Driven Translational Research to Optimize Bedside Therapeutics of Sotalol Therapy
por: Dahmane, Elyes, et al.
Publicado: (2019)

Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate: Evaluation of Dose Proportionality, Food Effect, Multiple-Dose Modeling, and Comparative Bioavailability with Immediate-Release Methylphenidate in Healthy Adults
por: Liu, Tao, et al.
Publicado: (2019)

Size segregation of irregular granular materials captured by time-resolved 3D imaging
por: Gajjar, Parmesh, et al.
Publicado: (2021)

Bioequivalence assessment of two formulations of ibuprofen
por: Al-Talla, Zeyad A, et al.
Publicado: (2011)

Pharmacokinetics and Bioequivalence Evaluation of Cyclobenzaprine Tablets
por: Brioschi, Tatiane Maria de Lima Souza, et al.
Publicado: (2013)

Focus on biosimilar etanercept – bioequivalence and interchangeability
por: Cantini, Fabrizio, et al.
Publicado: (2018)

The Case for Standardizing the Appearance of Bioequivalent Medications
por: Engelberg, Alfred B.
Publicado: (2011)

Between-Batch Bioequivalence (BBE): a Statistical Test to Evaluate In Vitro Bioequivalence Considering the Between-Batch Variability
por: Bodin, Jonathan, et al.
Publicado: (2020)

Current Bioequivalence Study Designs in South Korea: A Comprehensive Analysis of Bioequivalence Study Reports Between 2013 and 2019
por: Huh, Ki Young, et al.
Publicado: (2021)

Evaluation of Pharmacokinetics and Safety with Bioequivalence of Ibuprofen Sustained-Release Capsules of Two Formulations, in Chinese Healthy Volunteers: Bioequivalence Study
por: Huang, Chunqi, et al.
Publicado: (2023)

Bioequivalence study of cyclosporine in renal transplant recipients
por: Gautam, Gagan
Publicado: (2007)

Sample Size Determination for Individual Bioequivalence Inference
por: Chiang, Chieh, et al.
Publicado: (2014)

Evaluation of Bioequivalence of Two Oral Formulations of Olanzapine
por: Singhal, R., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_81nsbdvnofncu24kn45hcf2rud